A local pharmaceutical company supports patients worldwide
The Duchesnay Pharmaceutical Group (DPG) began when Louis Boivin acquired the Duchesnay pharmaceutical company in 1970. Today, DPG is owned by a team of leaders who are diversifying the company’s portfolio and proudly pursuing its mission in North America and abroad, focusing on women’s health and the treatment of rare diseases in particular.
How they’re changing the game
DPG develops new medicines, offering new therapeutic options to improve patients' health and quality of life.
From its state-of-the-art head office and manufacturing facility in Blainville, Quebec, DPG exports its innovative treatments to over 50 countries through strategic alliances, a business model unique to Canada. DPG has an inclusive and flexible internal culture, is deeply committed to environmental responsibility and gives back to the community by supporting various charitable organizations. GHP will work with DPG to support its mission to help people get healthy and stay healthy.